Julien Blouin

Stock Analyst at Goldman Sachs

(3.46)
# 907
Out of 5,124 analysts
28
Total ratings
61.9%
Success rate
3.64%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $37.13
Upside: +1.00%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $16.68
Upside: +1.92%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $334.94
Upside: +21.51%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $106.57
Upside: -0.53%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $30.97
Upside: +19.47%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $15.12
Upside: +32.28%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $31.01
Upside: +1.58%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.41
Upside: +62.82%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $16.18
Upside: +5.07%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $134.14
Upside: +8.10%
Initiates: Buy
Price Target: $176
Current: $166.18
Upside: +5.91%
Initiates: Neutral
Price Target: $318
Current: $251.49
Upside: +26.45%
Initiates: Neutral
Price Target: $81
Current: $61.77
Upside: +31.13%
Initiates: Buy
Price Target: $187
Current: $130.72
Upside: +43.05%